SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
小夏
Lv4
430 积分
2022-11-14 加入
最近求助
最近应助
互助留言
Long-term Survival and Excellent Response to Repeated 177Lu–Prostate-Specific Membrane Antigen 617 Radioligand Therapy in a Patient With Advanced Metastatic Castration-Resistant Prostate Cancer
5天前
已完结
Leveraging Programmatic Collaboration for a Radiopharmaceutical Clinic
8天前
已完结
177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice
8天前
已完结
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial
13天前
已完结
Comparison of 18F-PSMA-1007 and 18F-Choline PET/CT in prostate cancer patients with biochemical recurrence: a phase 3, prospective, multicenter, randomized study
17天前
已完结
Head-to-Head Comparison of 68Ga-PSMA-11 with 68Ga-P137 in Patients with Suspected Prostate Cancer
17天前
已完结
Diagnostic accuracy of 18F-fluciclovine PET/CT in primary lymph node staging of prostate cancer
19天前
已完结
18F-PSMA-11 Versus 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial
20天前
已完结
Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1–S Transition
30天前
已完结
A Phase 1, Open-label, Dose-Ascending Study to Evaluate the Safety and Tolerability of the Therapeutic Radiopharmaceutical 131I-MIP-1095 for the Treatment of Metastatic Castration-Resistant Prostate Cancer
1个月前
已完结
没有进行任何应助
已找到【积分已退回】
1个月前
文献有误【积分已退回】
2个月前
文件不一致,不是原文对应发表的补充材料,仅为阿斯利康公司出版的研究设计全文
4个月前
暂不需要了【积分已退回】
5个月前
已经找到【积分已退回】
7个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论